Trxade Health (Trxade Health) Risk Assessment

View and export this data going back to 2008. Start your Free Trial

What is Trxade Health Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Trxade Health is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of Trxade Health's Risk Assessment

For the Pharmaceutical Retailers subindustry, Trxade Health's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trxade Health's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Trxade Health's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Trxade Health's Risk Assessment falls into.

Trxade Health (NAS:MEDS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Trxade Health Risk Assessment Related Terms

Thank you for viewing the detailed overview of Trxade Health's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Trxade Health (Trxade Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trxade Health Inc (NAS:MEDS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

2420 Brunello Trace., Lutz, FL, USA, 33558

Website

https://www.rx.trxade.com

Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its product and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Community Specialty Pharmacy, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.

Executives

A. Jeffrey Newell	director	645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell	director	17537 DARBY LANE, LUTZ FL 33558
Janet Huffman	officer: CFO, PAO, PFO	5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson	director	17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings	director	3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel	director, 10 percent owner, officer: President	17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts	director	PO BOX 15012, SARASOTA FL 34277
Gary Augusta	director	700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss	officer: CFO	17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu	director, 10 percent owner, officer: CEO	8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida	director	1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope	director	4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu	10 percent owner	17537 DARBY LANE, LUTZ FL 33558